Free Trial
→ A new rule goes live in July — and the banks are quietly crushing it (From American Alternative) (Ad)
NASDAQ:GCTK

GlucoTrack 8/14/2023 Earnings Report

GlucoTrack logo
$5.82 +0.01 (+0.17%)
Closing price 08/8/2025 04:00 PM Eastern
Extended Trading
$5.84 +0.02 (+0.43%)
As of 08/8/2025 07:35 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
ProfileEarnings History

GlucoTrack EPS Results

Actual EPS
-$540.00
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

GlucoTrack Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

GlucoTrack Announcement Details

Quarter
Date
8/14/2023
Time
N/A
Conference Call Date
N/A
Conference Call Time
N/A

Upcoming Earnings

GlucoTrack's Q2 2025 earnings is scheduled for Tuesday, August 12, 2025, with a conference call scheduled on Friday, August 15, 2025 at 4:00 PM ET. Check back for transcripts, audio, and key financial metrics as they become available.

Conference Call Resources

GlucoTrack Earnings Headlines

Glucotrack Expands Clinical Advisory Team Appointing David S. Hirsh, MD as Medical Director, Cardiology
August 6 at 8:30 AM  |  globenewswire.comhttps://www.globenewswire.com/news-release/2025/08/06/3128336/0/en/glucotrack-expands-clinical-advisory-team-appointing-david-s-hirsh-md-as-medical-director-cardiology.html
GlucoTrack (NASDAQ:GCTK) Shares Down 3.2% - Here's What Happened
August 6 at 3:49 AM  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=30259481
A new rule goes live in July — and the banks are quietly crushing it
A little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Street and the Big Banks… It gives them the green light to treat a certain tangible asset as equivalent to cold, hard cash. Not stocks. Not real estate. And definitely not the U.S. dollar. We're talking about something they don't want you to notice — because the fewer people who act on this, the better it is for them.
 |  American Alternative (Ad)
GlucoTrack to Showcase CBGM at Diabetes Meeting
August 1, 2025  |  msn.comhttps://www.msn.com/en-us/health/other/glucotrack-to-showcase-cbgm-at-diabetes-meeting/ar-AA1JFlTF
Glucotrack to Exhibit at 2025 Association of Diabetes Care and Education Specialists Annual Meeting
July 31, 2025  |  globenewswire.comhttps://www.globenewswire.com/news-release/2025/07/31/3124984/0/en/glucotrack-to-exhibit-at-2025-association-of-diabetes-care-and-education-specialists-annual-meeting.html
GlucoTrack, Sarepta, TNF Pharma Dominate Weekly Retail Health Care Buzz — Here’s Why
July 21, 2025  |  msn.comhttps://www.msn.com/en-us/health/diseases-and-conditions/glucotrack-sarepta-tnf-pharma-dominate-weekly-retail-health-care-buzz-here-s-why/ar-AA1IXVAP
See More GlucoTrack Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like GlucoTrack? Sign up for Earnings360's daily newsletter to receive timely earnings updates on GlucoTrack and other key companies, straight to your email.

About GlucoTrack

GlucoTrack (NASDAQ:GCTK), a medical device company, focused on the design, development, and commercialization of novel technologies for people with diabetes in the United States. It develops GlucoTrack, a noninvasive glucose monitoring device that helps people with diabetes and pre-diabetics to obtain blood glucose level readings without the pain. The company was formerly known as Integrity Applications, Inc. and changed its name to GlucoTrack, Inc. in November 2021. GlucoTrack, Inc. was founded in 2001 and is based in Rutherford, New Jersey.

View GlucoTrack Profile

More Earnings Resources from MarketBeat

Earnings Tools
Earnings By Country
Latest Articles